Compare MNPR & BBCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNPR | BBCQ |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.9M | 394.4M |
| IPO Year | 2019 | N/A |
| Metric | MNPR | BBCQ |
|---|---|---|
| Price | $59.35 | $10.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $107.00 | N/A |
| AVG Volume (30 Days) | 149.2K | ★ 622.8K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.18 | $9.92 |
| 52 Week High | $105.00 | $11.26 |
| Indicator | MNPR | BBCQ |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 46.52 |
| Support Level | $56.02 | $10.24 |
| Resistance Level | $60.67 | $10.44 |
| Average True Range (ATR) | 3.50 | 0.22 |
| MACD | -0.56 | -0.05 |
| Stochastic Oscillator | 15.69 | 6.40 |
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Bleichroeder Acquisition Corp II is a blank check company incorporated. The company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the company has not yet identified.